Company Filing History:
Years Active: 2004
Title: Tania Lessen - Innovator in Pharmaceutical Compositions
Introduction
Tania Lessen is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of azithromycin compositions. Her innovative work has the potential to enhance the effectiveness and shelf-life of important medications.
Latest Patents
Tania Lessen holds a patent for "Stabilized azithromycin compositions." This patent describes compositions and methods for stabilizing azithromycin, which is crucial for improving its resistance to degradation. The stabilized compositions consist of an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant. Preferred methods for achieving this admixture include coprecipitation or co-milling of azithromycin and an antioxidant. Additionally, the patent outlines pharmaceutical formulations that incorporate the stabilized azithromycin composition and methods for creating such formulations.
Career Highlights
Tania Lessen is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to focus on innovative solutions that address critical challenges in drug formulation and stability.
Collaborations
Tania collaborates with Ruth Tenengauzer, who is also a key figure in her field. Their partnership exemplifies the importance of teamwork in driving innovation within the pharmaceutical industry.
Conclusion
Tania Lessen's contributions to the stabilization of azithromycin compositions highlight her role as an influential inventor in the pharmaceutical sector. Her work not only advances drug formulation techniques but also enhances the efficacy of essential medications.